Invokana vs Metformin
A side-by-side look at two diabetes medications advertised on TV. Informational only — not medical advice.
Maintained by TVPills Editorial Team · Site updated November 4, 2026 (not a product-label review)
| Attribute | US Invokana | US Metformin |
|---|---|---|
| Generic name | canagliflozin Unverified catalogue summary (Generic name) for Invokana in US; not checked against current local product information. | metformin Unverified catalogue summary (Generic name) for Metformin in US; not checked against current local product information. |
| Drug class | See official local label Unverified catalogue summary (Drug class) for Invokana in US; not checked against current local product information. | See official local label Unverified catalogue summary (Drug class) for Metformin in US; not checked against current local product information. |
| Treats | Type 2 diabetes, diabetic kidney disease Unverified catalogue summary (Treats) for Invokana in US; not checked against current local product information. | Type 2 diabetes Unverified catalogue summary (Treats) for Metformin in US; not checked against current local product information. |
| Category | Diabetes Unverified catalogue summary (Category) for Invokana in US; not checked against current local product information. | Diabetes Unverified catalogue summary (Category) for Metformin in US; not checked against current local product information. |
| Manufacturer | Janssen Pharmaceuticals, Inc. (manufactured for) Unverified catalogue summary (Manufacturer) for Invokana in US; not checked against current local product information. | Various (generic) Unverified catalogue summary (Manufacturer) for Metformin in US; not checked against current local product information. |
| Year approved | — Unverified catalogue summary (Year approved) for Invokana in US; not checked against current local product information. | — Unverified catalogue summary (Year approved) for Metformin in US; not checked against current local product information. |
| Catalogue warning level | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Invokana in US; not checked against current local product information. | Safety summary withheld — check official label Unverified catalogue summary (Catalogue warning level) for Metformin in US; not checked against current local product information. |
| Est. TV ad spend | $110M | $2M |
| Side effects and serious risks | — Unverified catalogue summary (Side effects and serious risks) for Invokana in US; not checked against current local product information. | — Unverified catalogue summary (Side effects and serious risks) for Metformin in US; not checked against current local product information. |
Metformin
Sources and editorial standards
Use the current DailyMed labels to verify approved uses, boxed warnings, and side effects for each medication. Label results can differ by product, strength, and formulation.
Page updated November 4, 2026; the linked resources have not necessarily been reviewed on this date.
Frequently asked questions
Is Invokana or Metformin better?
This directory does not compare clinical effectiveness or safety. Listing Invokana and Metformin together does not establish shared approved indications, equivalence or suitability as substitutes. Consult the correct local labels and your prescriber.
What's the difference between Invokana and Metformin?
The table shows catalogue identification and estimated advertising information for Invokana and Metformin, not a verified medical comparison. Medical descriptions, mechanisms and safety summaries are withheld.
Which one spends more on TV ads?
Invokana has the larger estimated TV advertising budget of the two.